Why are drug prices so high? Investigating th...

When an organization lays people off , those who remain are often left scrambling to find their footing – and hold other people up – in an environment that no longer feels stable. In the wake of ongoing tech layoffs and the Trump administration’s efforts to reshape the public sec ...  Show more

Finance doesn't have to feel like a foreign language. Wall Street trader-turned-financial educator Vivian Tu helps millions of people make sense of money, breaking down complex concepts into everyday terms you can understand. She shares how she broke free from the stress of livin ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...